Replimune Group, Inc.

Not Rated
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US76029N1063
USD
10.53
0.53 (5.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Replimune Group, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-248.00
-217.00
-176.00
-121.00
-83.00
-55.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
24.00
5.00
15.00
7.00
3.00
-15.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-192.00
-185.00
-128.00
-82.00
-61.00
-60.00
Cash Flow from Investing Activities
-23.00
97.00
-142.00
-1.00
-188.00
-5.00
Cash Flow from Financing Activities
252.00
16.00
311.00
6.00
372.00
100.00
Net Cash Inflow / Outflow
36.00
-72.00
40.00
-76.00
123.00
34.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Replimune Group, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-248.602
-318.758
70.00
22.01%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
24.081
13.27
11.00
81.47%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-192.25
-274.903
82.00
30.07%
Cash Flow from Investing Activities
-23.796
-219.775
196.00
89.17%
Cash Flow from Financing Activities
252.396
353.367
-101.00
-28.57%
Net Cash Inflow / Outflow
36.665
-141.311
177.00
125.95%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.315
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -3.66% vs -44.84% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-192.25
-185.47
-3.66%